Adora Ndu
About Adora Ndu
Adora Ndu serves as the Chief Regulatory Affairs Officer at BridgeBio and has extensive experience in regulatory affairs and law, holding various leadership roles in the pharmaceutical industry and academia.
Current Role at BridgeBio
Adora Ndu serves as the Chief Regulatory Affairs Officer at BridgeBio. She has held this position since 2022. In this role, she is responsible for overseeing regulatory strategies and ensuring compliance with industry standards. Her leadership contributes to the company's mission of developing innovative therapies for genetic diseases.
Previous Experience at BridgeBio
Before her current role, Adora Ndu worked at BridgeBio as the Chief Regulatory and interim Legal Officer from 2022 to 2023. During her 11-month tenure, she played a critical role in shaping regulatory frameworks and policies that support the company's objectives in the biopharmaceutical sector.
Professional Background in Regulatory Affairs
Adora Ndu has extensive experience in regulatory affairs, having worked at BioMarin Pharmaceutical Inc. in various leadership roles. She served as Vice President of Regulatory Affairs, Policy, Research, Engagement & International from 2019 to 2020, and as Executive Director of Regulatory Affairs from 2017 to 2019. Her experience includes developing regulatory strategies and engaging with stakeholders to advance product development.
Education and Credentials
Adora Ndu holds a Doctor of Pharmacy (PharmD) from Howard University. She also earned a Doctor of Law (J.D.) from the University of Maryland Francis King Carey School of Law. Additionally, she completed Executive Education at Harvard Business School in 2018. Her educational background equips her with a strong foundation in both pharmacy and law, enhancing her expertise in regulatory affairs.
Board Memberships and Academic Involvement
Adora Ndu is actively involved in governance as a member of the Board of Directors at DBV Technologies since 2021 and Acadia Pharmaceuticals Inc. since 2022. She also contributes to academia as Adjunct Faculty at The Johns Hopkins University, teaching in the Masters in Biotechnology Enterprise and Entrepreneurship program since 2019. Her roles in both industry and education reflect her commitment to advancing the field of biotechnology.